from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1975/-

LFCtreatmentdescriptionclass of inhibitor

-0.349

Amikacinug/mL Amikacintranslation

-0.231

Cap5-10ug/mL Capreomycintranslation

0.318

Rox10-50 ug/mL Roxithromycintranslation

0.774

SM2-5 ug/mL Streptomycintranslation

-0.417

Tet5-10 ug/mL Tetracyclinetranslation

-1.248

Rif0.2-5ug/mL Rifampicintranscription

-0.551

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.526

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.175

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.050

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.825

Clofazimine10-13 ug/mL Clofaziminerespiration

0.060

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.429

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.540

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.118

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.561

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.436

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.224

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.198

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.863

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.829

KCN5-20 ug/mL Potassium cyaniderespiration

0.676

NaN30.2-2 mM Sodium aziderespiration

0.803

Nigericin50 uM Nigericinrespiration

-0.167

TRC10-150 ug/mL Triclosanrespiration

-0.172

TRZ10-25 ug/mL Thioridazinerespiration

1.588

Valinomycin0.5-10 uM Valinomycinrespiration

-0.912

ZnSO42 mM ZnSO4respiration

1.670

menadione6-10 ug/mL Menadionerespiration

0.220

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.567

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.675

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.323

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.379

NRP_1Non-replicating persistence stage 1dosRassociated

-0.008

Amp0.2mg/mL AmpicillincellWall

-0.499

Cephalexin20-100 ug/mL CephalexincellWall

-0.250

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.417

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.215

EMB10-20 ug/mL EthambutolcellWall

-0.094

Eta12-40 ug/mL EthionamidecellWall

-0.291

INH0.2-0.4 ug/mL IsoniazidcellWall

0.229

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.351

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.345

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.835

BZA0.12 mg/mL BenzamidearomaticAmides

0.091

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.291

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.575

H2O24 mM hydrogen peroxideDNAdamaging

-0.202

Levo10 ug/mL LevofloxacinDNAdamaging

-0.002

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.273

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.196

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.111

UVUV-irradiationDNAdamaging

0.441

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.386

Antimycin12.5-50 ug/mL Antimycin A?

-0.142

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.552

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.227

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.029

PA8240.2-2 ug/mL PA-824?

-0.844

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.851

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.497

Verapamil50 uM Verapamil?

0.376

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.011

methoxatin10-20 ug/mL Methoxatin?